http://dspace.bsu.edu.ru/handle/123456789/46375| Title: | Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives |
| Authors: | Danilenko, L. M. |
| Keywords: | medicine pharmacology meldonium doxorubicin cardiopathy isolated rat heart doxorubicin-associated cardiomyopathy |
| Issue Date: | 2018 |
| Citation: | Danilenko, L.M. Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives / L.M. Danilenko // Research result: pharmacology and clinical pharmacology. - 2018. - Vol. 4, № 1.- P. 81-86. - DOI: 10.3897/rrpharmacology. 4.25530. |
| Abstract: | The cardioprotective effect of the derivatives (nicotinate, 5-hydroxynicotinate) of 3-(2,2,2-trimethylhydrazini- um) propionate) and reference medicine meldonium in the case of doxorubicin (DOX) (20 mg/kg, intraperitoneally for 48 hours) cardiomyopathy was evaluated by the results of a functional test with high-frequency stimulation (480 bpm) |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/46375 |
| Appears in Collections: | Vol. 4, № 1 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Danilenko_Doxorubicin_18.pdf | 545.04 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.